Cargando…

Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells

The inhibition of bone healing in humans is a well-established effect associated with cigarette smoking, but the underlying mechanisms are still unclear. Recent work using animal cell lines have implicated the aryl hydrocarbon receptor (AhR) as a mediator of the anti-osteogenic effects of cigarette...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Chawon, Katchko, Karina M., Schallmo, Michael S., Jeong, Soyeon, Yun, Jonghwa, Chen, Charlotte H., Weiner, Joseph A., Park, Christian, George, Andrew, Stupp, Samuel I., Hsu, Wellington K., Hsu, Erin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796174/
https://www.ncbi.nlm.nih.gov/pubmed/29324662
http://dx.doi.org/10.3390/ijms19010225
_version_ 1783297450375643136
author Yun, Chawon
Katchko, Karina M.
Schallmo, Michael S.
Jeong, Soyeon
Yun, Jonghwa
Chen, Charlotte H.
Weiner, Joseph A.
Park, Christian
George, Andrew
Stupp, Samuel I.
Hsu, Wellington K.
Hsu, Erin L.
author_facet Yun, Chawon
Katchko, Karina M.
Schallmo, Michael S.
Jeong, Soyeon
Yun, Jonghwa
Chen, Charlotte H.
Weiner, Joseph A.
Park, Christian
George, Andrew
Stupp, Samuel I.
Hsu, Wellington K.
Hsu, Erin L.
author_sort Yun, Chawon
collection PubMed
description The inhibition of bone healing in humans is a well-established effect associated with cigarette smoking, but the underlying mechanisms are still unclear. Recent work using animal cell lines have implicated the aryl hydrocarbon receptor (AhR) as a mediator of the anti-osteogenic effects of cigarette smoke, but the complexity of cigarette smoke mixtures makes understanding the mechanisms of action a major challenge. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, dioxin) is a high-affinity AhR ligand that is frequently used to investigate biological processes impacted by AhR activation. Since there are dozens of AhR ligands present in cigarette smoke, we utilized dioxin as a prototype ligand to activate the receptor and explore its effects on pro-osteogenic biomarkers and other factors critical to osteogenesis using a human osteoblast-like cell line. We also explored the capacity for AhR antagonists to protect against dioxin action in this context. We found dioxin to inhibit osteogenic differentiation, whereas co-treatment with various AhR antagonists protected against dioxin action. Dioxin also negatively impacted cell adhesion with a corresponding reduction in the expression of integrin and cadherin proteins, which are known to be involved in this process. Similarly, the dioxin-mediated inhibition of cell migration correlated with reduced expression of the chemokine receptor CXCR4 and its ligand, CXCL12, and co-treatment with antagonists restored migratory capacity. Our results suggest that AhR activation may play a role in the bone regenerative response in humans exposed to AhR activators, such as those present in cigarette smoke. Given the similarity of our results using a human cell line to previous work done in murine cells, animal models may yield data relevant to the human setting. In addition, the AhR may represent a potential therapeutic target for orthopedic patients who smoke cigarettes, or those who are exposed to secondhand smoke or other environmental sources of aryl hydrocarbons.
format Online
Article
Text
id pubmed-5796174
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57961742018-02-09 Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells Yun, Chawon Katchko, Karina M. Schallmo, Michael S. Jeong, Soyeon Yun, Jonghwa Chen, Charlotte H. Weiner, Joseph A. Park, Christian George, Andrew Stupp, Samuel I. Hsu, Wellington K. Hsu, Erin L. Int J Mol Sci Article The inhibition of bone healing in humans is a well-established effect associated with cigarette smoking, but the underlying mechanisms are still unclear. Recent work using animal cell lines have implicated the aryl hydrocarbon receptor (AhR) as a mediator of the anti-osteogenic effects of cigarette smoke, but the complexity of cigarette smoke mixtures makes understanding the mechanisms of action a major challenge. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, dioxin) is a high-affinity AhR ligand that is frequently used to investigate biological processes impacted by AhR activation. Since there are dozens of AhR ligands present in cigarette smoke, we utilized dioxin as a prototype ligand to activate the receptor and explore its effects on pro-osteogenic biomarkers and other factors critical to osteogenesis using a human osteoblast-like cell line. We also explored the capacity for AhR antagonists to protect against dioxin action in this context. We found dioxin to inhibit osteogenic differentiation, whereas co-treatment with various AhR antagonists protected against dioxin action. Dioxin also negatively impacted cell adhesion with a corresponding reduction in the expression of integrin and cadherin proteins, which are known to be involved in this process. Similarly, the dioxin-mediated inhibition of cell migration correlated with reduced expression of the chemokine receptor CXCR4 and its ligand, CXCL12, and co-treatment with antagonists restored migratory capacity. Our results suggest that AhR activation may play a role in the bone regenerative response in humans exposed to AhR activators, such as those present in cigarette smoke. Given the similarity of our results using a human cell line to previous work done in murine cells, animal models may yield data relevant to the human setting. In addition, the AhR may represent a potential therapeutic target for orthopedic patients who smoke cigarettes, or those who are exposed to secondhand smoke or other environmental sources of aryl hydrocarbons. MDPI 2018-01-11 /pmc/articles/PMC5796174/ /pubmed/29324662 http://dx.doi.org/10.3390/ijms19010225 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yun, Chawon
Katchko, Karina M.
Schallmo, Michael S.
Jeong, Soyeon
Yun, Jonghwa
Chen, Charlotte H.
Weiner, Joseph A.
Park, Christian
George, Andrew
Stupp, Samuel I.
Hsu, Wellington K.
Hsu, Erin L.
Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells
title Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells
title_full Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells
title_fullStr Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells
title_full_unstemmed Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells
title_short Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells
title_sort aryl hydrocarbon receptor antagonists mitigate the effects of dioxin on critical cellular functions in differentiating human osteoblast-like cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796174/
https://www.ncbi.nlm.nih.gov/pubmed/29324662
http://dx.doi.org/10.3390/ijms19010225
work_keys_str_mv AT yunchawon arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT katchkokarinam arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT schallmomichaels arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT jeongsoyeon arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT yunjonghwa arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT chencharlotteh arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT weinerjosepha arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT parkchristian arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT georgeandrew arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT stuppsamueli arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT hsuwellingtonk arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells
AT hsuerinl arylhydrocarbonreceptorantagonistsmitigatetheeffectsofdioxinoncriticalcellularfunctionsindifferentiatinghumanosteoblastlikecells